Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors

被引:97
作者
Immormino, Robert M.
Kang, Yanlong
Chiosis, Gabriela
Gewirth, Daniel T. [1 ]
机构
[1] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA
[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Program Mol Pharmacol & Chem, New York, NY 10021 USA
关键词
N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; PURINE-SCAFFOLD; PROTEIN; GELDANAMYCIN; BINDING; IDENTIFICATION; CONFORMATION; CELLS; CRYSTALLOGRAPHY;
D O I
10.1021/jm060297x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hsp90 chaperones play a critical role in modulating the activity of many cell signaling proteins and are an attractive target for anti-cancer therapeutics. We report here the structures of the water soluble 8-arylsulfanyl adenine class Hsp90 inhibitors, 1 (PU-H71) and 2 (PU-H64), in complex with the N-terminal domain of human Hsp90 alpha. The conformation of 1 when bound to Hsp90 differs from previously reported 8-aryl adenine Hsp90 inhibitors including 3 (PU24FCl). While the binding mode for 3 places the 2'-halide of the 8-aryl group on top of the adenine ring, for 1 and 2, we show that the 2'-halide is rotated approximately 180 away. This difference explains the opposing trends in Hsp90 inhibitory activity for the 2'-halo derivatives of the 3', 4', 5'-trimethoxy series where Cl > Br > I compared to the 4', 5'-methylenedioxy series where I > Br > Cl. We also present quantum chemical calculations of 2 and its analogues that illuminate their basis for Hsp90 inhibition. The calculated conformation of 2 agreed well with the crystallographically observed conformations of 1 and 2. The predictive nature of the calculations has allowed the exploration of additional derivatives based on the 8-aryl adenine scaffold.
引用
收藏
页码:4953 / 4960
页数:8
相关论文
共 45 条
[1]   The Protein Data Bank and the challenge of structural genomics [J].
Berman, HM ;
Bhat, TN ;
Bourne, PE ;
Feng, ZK ;
Gilliland, G ;
Weissig, H ;
Westbrook, J .
NATURE STRUCTURAL BIOLOGY, 2000, 7 (Suppl 11) :957-959
[2]   Orally active purine-based inhibitors of the heat shock protein 90 [J].
Biamonte, MA ;
Shi, JD ;
Hong, K ;
Hurst, DC ;
Zhang, L ;
Fan, JH ;
Busch, DJ ;
Karjian, PL ;
Maldonado, AA ;
Sensintaffar, JL ;
Yang, YC ;
Kamal, A ;
Lough, RE ;
Lundgren, K ;
Burrows, FJ ;
Timony, GA ;
Boehm, MF ;
Kasibhatla, SR .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :817-828
[3]   The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy [J].
Blagosklonny, MV ;
Fojo, T ;
Bhalla, KN ;
Kim, JS ;
Trepel, JB ;
Figg, WD ;
Rivera, Y ;
Neckers, LM .
LEUKEMIA, 2001, 15 (10) :1537-1543
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   ATPases as drug targets:: Learning from their structure [J].
Chène, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :665-673
[6]   The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors [J].
Cheung, KMJ ;
Matthews, TP ;
James, K ;
Rowlands, MG ;
Boxall, KJ ;
Sharp, SY ;
Maloney, A ;
Roe, SM ;
Prodromou, C ;
Pearl, LH ;
Aherne, GW ;
McDonald, E ;
Workman, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) :3338-3343
[7]   Hsp90: the vulnerable chaperone [J].
Chiosis, G ;
Vilenchik, M ;
Kim, J ;
Solit, D .
DRUG DISCOVERY TODAY, 2004, 9 (20) :881-888
[8]   A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells [J].
Chiosis, G ;
Timaul, MN ;
Lucas, B ;
Munster, PN ;
Zheng, FF ;
Sepp-Lorenzino, L ;
Rosen, N .
CHEMISTRY & BIOLOGY, 2001, 8 (03) :289-299
[9]   Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase [J].
Chiosis, G ;
Lucas, B ;
Shtil, A ;
Huezo, H ;
Rosen, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) :3555-3564
[10]   Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide [J].
Clevenger, RC ;
Blagg, BSJ .
ORGANIC LETTERS, 2004, 6 (24) :4459-4462